Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07341334 · ClinicalTrials.gov registry record
Digital Speech Markers for Monitoring ALS in Spanish Speakers
A clinical trial, sponsored by Nova Southeastern University.
- Not yet
- Registry status
- 35
- Enrollment target
NCT07341334: Clinical Trial study, sponsored by Nova Southeastern University.
NCT07341334 is a clinical trial that has not yet begun recruiting, run by Nova Southeastern University. The registered enrollment target is 35 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07341334 has not yet begun recruiting, sponsored by Nova Southeastern University.
- NOT YET RECRUITING
- Registry status
- 35 participants
- Enrollment target
Study Summary
The goal of this observational study is to learn how speech and breathing change over time in Spanish-speaking individuals with amyotrophic lateral sclerosis (ALS) compared to age- and gender-matched individuals without ALS. The main questions it aims to answer are: Can speech and breathing measures collected through a smartphone application serve as reliable digital biomarkers to track bulbar disease decline in Spanish-speaking people with ALS? How do these measures differ between individuals with ALS and those without ALS? Researchers will compare Spanish-speaking participants with ALS to age- and gender-matched healthy controls to see if specific speech and breathing features can identify or predict bulbar decline. Participants will: Use a Spanish-language smartphone application to record speech and breathing tasks over time. Complete assessments of speech, breathing, and functional abilities (e.g., ALS Functional Rating Scale). Provide data that will be compared to caregiver reports and clinical outcomes to validate new digital biomarkers.
Primary Outcome
Speaking rate (words per minute): a measure of the rate of speech during oral reading.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2026-04 |
| Est. Completion | 2029-12 |
What is known before NCT07341334 opens enrollment
NCT07341334 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 35 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT07341334 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07341334 about?
NCT07341334 is a clinical study titled "Digital Speech Markers for Monitoring ALS in Spanish Speakers". The goal of this observational study is to learn how speech and breathing change over time in Spanish-speaking individuals with amyotrophic lateral sclerosis (ALS) compared to age- and gender-matched individuals without ALS. The main questions it aims to answer are: Can speech and breathing measur...
What is the current status of trial NCT07341334?
This trial is currently not yet recruiting. The enrollment target is 35 participants. The study started on 2026-04. Estimated completion is 2029-12.
Who is sponsoring clinical trial NCT07341334?
This trial is sponsored by Nova Southeastern University, which has 71 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia